Source link : https://www.newshealth.biz/health-news/baricitinib-plus-phototherapy-beneficial-for-severe-vitiligo/
TOPLINE: Baricitinib, a Janus kinase (JAK) inhibitor, combined with narrowband ultraviolet B (UVB) phototherapy, reduced disease activity and improved repigmentation and quality of life in adults with extensive and active vitiligo, in a phase 2 study. METHODOLOGY: A multicenter, double-blind, proof-of-concept phase 2 randomized clinical trial included 49 adults (71% women; median age, 49.9 years) […]
Author : News Health
Publish date : 2025-01-22 16:00:00
Copyright for syndicated content belongs to the linked Source.